Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]

BMC Cancer201919:97

https://doi.org/10.1186/s12885-019-5297-x

  • Received: 9 January 2019
  • Accepted: 9 January 2019
  • Published:

The original article was published in BMC Cancer 2019 19:18

Correction to: BMC Cancer

https://doi.org/10.1186/s12885-018-5200-1

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected.
  • Originally published name:
    • Nicholas Nicholas G. Nickols

  • Correct name:
    • Nicholas G. Nickols

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Molecular & Medical Pharmacology, Ahmanson Translational Theranostics/ Imaging Division, University of California, Los Angeles, USA
(2)
Department of Nuclear Medicine, University Hospital Essen, Essen, Germany
(3)
Department of Medicine Statistics Core (DOMStat), UCLA CTSI Biostatistics and Computational Biology, University of California, Los Angeles, USA
(4)
Department of Radiation Oncology, University of California, Los Angeles, USA
(5)
Department of Radiation Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA

Reference

  1. Calais, et al. Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]. BMC Cancer. 2018;19:18. https://doi.org/10.1186/s12885-018-5200-1.View ArticleGoogle Scholar

Copyright

© The Author(s). 2019

Advertisement